Contact us
Text Size
Large
Small
[This site uses JavaScript. Please do effectively and see the setting of JavaScript.]
About Takeda
Responsibility
Patient Assistance Program
Community Involvement
Culture of Compliance
R&D
Products
Newsroom
2009
2008
2007
2006
2005
2004
2003
Press Center
Careers
Jobs
Submit Resume
Home
>
Newsroom
2009
2008
2007
2006
2005
2004
2003
Press Center
News and Press Releases
2009
June 26, 2009
Takeda Receives FDA Complete Response Letter for Alogliptin, An Investigational Treatment for Type 2 Diabetes
May 13, 2009
FDA Approves ACTO
plus
met® XR (pioglitazone HCl and metformin HCl extended-release) Tablets for the Treatment of Type 2 Diabetes
March 31, 2009
Takeda to Create Global Centers of Excellence
March 12, 2009
ULORIC® (febuxostat) 40-mg and 80-mg Tablets Now Available for the Chronic Management of Hyperuricemia in Patients with Gout
February 23, 2009
KAPIDEX™ (dexlansoprazole) delayed release capsules Now Available for the Treatment of GERD
February 13, 2009
FDA Approves ULORIC® (febuxostat) for the Chronic Management of Hyperuricemia in Patients with Gout
January 30, 2009
FDA Approves KAPIDEX™ (dexlansoprazole) delayed release capsules for the Treatment of GERD
January 19, 2009
Review of Takeda’s Febuxostat New Drug Application Continues Past PDUFA Date
Page Top